Seres Therapeutics (MCRB) Financials

$5.28

$-0.28 (-5.04%)

As on 09-Sep-2026 16:00EDT

Market cap

$57 Mln

Revenue (TTM)

$2 Mln

P/E Ratio

--

P/B Ratio

1.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	1.88	0.79	--	126.33	7.13	144.93
Cost of Revenue	0.33	4.13	3.53	19.34	1.00	141.89
Gross Profit	1.56	-3.34	-3.53	-19.34	6.12	144.93
Operating Expenses	85.59	90.63	117.78	175.76	179.91	209.42
Operating Profit (EBIT)	-84.03	-93.97	-121.32	-195.10	-179.91	-64.49
Other Income	--	--	--	--	2.35	1.83
Profit before Tax	-22.46	5.70	-125.77	-190.13	-183.58	-65.58
Provision for Tax	--	--	0.14	14.95	3.67	-4.08
Profit after Tax (Net Income)	-22.46	5.70	-146.57	-113.72	-250.16	-65.58
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-250.16	-65.58

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	34.53	44.22	13.78	-44.86	10.78	131.51
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	47.02	74.65	84.80	304.80	252.41	141.09
Current Liabilities	20.03	19.32	41.22	98.66	85.60	82.26
Total Liabilities	121.62	138.19	139.81	358.60	348.78	354.86

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	59.24	88.82	101.14	183.19	154.02	51.23
Current Assets	42.35	49.38	38.67	175.41	194.76	303.63
Total Assets	121.62	138.19	139.81	358.60	348.78	354.86
Total Debt*	56.64	82.97	91.64	198.78	162.59	49.21
Net Current Assets	22.32	30.05	-2.55	76.75	109.17	221.37

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	1.12	-148.61	-117.35	-228.82	6.69
Cash Flow from Investing Activities	--	-0.04	142.29	10.58	82.43	64.09
Cash from Financing Activities	--	13.90	-90.37	71.71	129.60	1.18
Net Cash Inflow / Outflow	--	--	--	--	-16.79	71.95

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.40	0.64	-16.94	-17.60	-39.95	-14.27
Cash EPS ($)	--	1.11	-16.31	-16.63	-38.90	-12.98
Adjusted Book Value ($)	--	4.99	1.59	--	1.72	28.62
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.13	-17.18	-18.16	-36.55	1.46
Free Cash Flow per Share ($)	--	0.10	-17.22	-19.39	-38.11	-0.63

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	4.90	-113.03	-69.49	-141.30	-33.10
ROE (%)	-57.05	19.64	943.43	667.53	-351.62	-42.83
ROA (%)	-15.16	4.10	-58.82	-32.15	-71.10	-18.80
EBIT Margin (%)	-1,436.22	721.93	--	-148.55	-2,491.04	-43.24
Net Margin (%)	-1,192.94	721.93	--	-90.02	-2,638.51	-44.69
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-68.40	--	-1.00	16.72	-0.95	3.36
EBIT Growth (%)	49.77	104.53	32.98	-5.69	-183.34	27.30
Net Profit Growth (%)	-126.13	103.89	-28.88	54.54	-281.46	26.42
EPS Growth (%)	-121.20	1.04	0.04	0.56	-1.80	0.27
Book Value Growth (%)	-4.98	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	23.17	-0.05	-0.08	-0.14	-0.58
Price / Book Value	1.51	2.98	0.52	-0.20	3.25	0.29
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	3.74	17.21	-0.57	-0.44	-0.10	3.58
Close Price ($)	7.89	14.88	16.62	28.00	112.00	166.60
High Price ($)	29.98	29.98	41.00	137.40	189.80	598.00
Low Price ($)	5.31	6.53	10.80	18.20	50.00	108.20
Market Cap ($ Cr)	57.46	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	1.88	6.65	-4.43	15.08	0.37
Short term debt to equity ratio	0.34	0.23	0.63	-0.12	0.38	0.05
Current Ratio	2.11	2.56	0.94	1.78	2.28	3.69
Quick Ratio	2.11	--	--	1.48	2.28	--
Interest Coverage	--	--	--	-14.24	-29.50	-21.54

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	1,342.22	45.63	--	6.87	--	--
Asset Turnover	0.01	0.01	--	0.36	0.02	0.42
Receivable days	--	1,183.01	--	25.08	--	11.83
Inventory Days	--	--	3,065.85	279.94	--	0.00
Payable days	--	254.56	399.17	199.05	5,670.65	22.85
Cash Conversion Cycle	--	--	--	105.96	-5,670.65	-11.02

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.